{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:39Z","timestamp":1786120299992,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/rlu.0b013e318238f51a","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T03:54:58Z","timestamp":1326167698000},"page":"158-163","source":"Crossref","is-referenced-by-count":65,"title":["Comparison of F-18 FDG and C-11 Methionine PET\/CT for the Evaluation of Recurrent Primary Brain Tumors"],"prefix":"10.1097","volume":"37","author":[{"given":"Madhavi","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raunak","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Jaimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M. D.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspriya","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00256026","article-title":". Non-selective transport of C-11-methyl-L and D-methionine into a malignant glioma.","volume":"13","author":"Schober","year":"1987","journal-title":"Eur J Nucl Med"},{"key":"R2-8-20210204","first-page":"778","article-title":". Pre-operative evaluation of 54 gliomas by PET with F-18 FDG andor C-11 Methionine.","volume":"39","author":"Kaschten","year":"1998","journal-title":"J Nucl Med"},{"key":"R3-8-20210204","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1227\/00006123-198911000-00006","article-title":". C-11-methionine uptake in gliomas.","volume":"25","author":"Derlon","year":"1989","journal-title":"Neurosurgery"},{"key":"R4-8-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/028418519103200302","article-title":". Clinical value of PET with F-18-flurodeoxyglucose and L-methyl-C11-methionine for diagnosis of recurrent brain tumor and radiation injury.","volume":"32","author":"Ogawa","year":"1991","journal-title":"Acta Radiol"},{"key":"R5-8-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00259-004-1564-3","article-title":". Direct comparison of f-18 FDG and C-11 methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.","volume":"32","author":"Laere","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-8-20210204","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","article-title":". Usefulness of C-11 methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on F-18 FDG PET.","volume":"29","author":"Chung","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-8-20210204","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3171\/jns.2001.95.5.0746","article-title":". Positron emission tomography with injection of methionine as a prognostic factor in glioma.","volume":"95","author":"De Witte","year":"2001","journal-title":"J Neurosurg"},{"key":"R8-8-20210204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00259-004-1598-6","article-title":". C-11 methionine PET as a prognostic marker in patients with glioma: comparison with F-18 FDG PET.","volume":"32","author":"Kim","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-8-20210204","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00004728-198507010-00005","article-title":". PET with (C-11methyl)-L-methionine, C-11Dglucose, and Ga-68EDTA in supratentorial tumors.","volume":"9","author":"Ericson","year":"1985","journal-title":"J Comput Assist Tomogr"},{"key":"R10-8-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2967\/jnumed.109.068783","article-title":". Evaluation of the accumulation of C-11 methionine with standardized uptake value in the normal brain.","volume":"51","author":"Uda","year":"2010","journal-title":"J Nucl Med"},{"key":"R11-8-20210204","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2967\/jnumed.107.048082","article-title":". Diagnostic accuracy of C-11 methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.","volume":"49","author":"Terakawa","year":"2008","journal-title":"J Nucl Med"},{"key":"R12-8-20210204","first-page":"1861","article-title":"PET in differentiation of recurrent brain tumor from radiation injury.","volume":"41","author":"Langleben","year":"2000","journal-title":"J Nucl Med"},{"key":"R13-8-20210204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.0.CO;2-7","article-title":". 18-Flurodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.","volume":"79","author":"Barker","year":"1997","journal-title":"Cancer"},{"key":"R14-8-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.1016","article-title":". Sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.","volume":"96","author":"Chao","year":"2001","journal-title":"Int J Cancer"},{"key":"R15-8-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","article-title":". Optimal cutoff levels of F-18 flurodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.","volume":"195","author":"Delbeke","year":"1995","journal-title":"Radiology"},{"key":"R16-8-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","article-title":". O-(2-18Ffluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.","volume":"33","author":"Langen","year":"2006","journal-title":"Nucl Med Biol"},{"key":"R17-8-20210204","first-page":"205","article-title":". Synthesis and radiopharmacology of O-(2-18Ffluoroethyl)-L-tyrosine for tumor imaging.","volume":"40","author":"Wester","year":"1999","journal-title":"J Nucl Med"},{"key":"R18-8-20210204","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","article-title":". O-(2-18Ffluoroethyl)-L-tyrosine and L-methyl-11Cmethionine uptake in brain tumors: initial results of a comparative study.","volume":"27","author":"Weber","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R19-8-20210204","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0969-8051(03)00023-4","article-title":". Comparison of flurotyrosines and methionine uptake in F98 rat gliomas.","volume":"30","author":"Langen","year":"2003","journal-title":"Nucl Med Biol"},{"key":"R20-8-20210204","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","article-title":". O-(2-18FFluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.","volume":"128","author":"Pauleit","year":"2005","journal-title":"Brain"},{"key":"R21-8-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","article-title":". Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.","volume":"48","author":"Floeth","year":"2007","journal-title":"J Nucl Med"},{"key":"R22-8-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-009-9896-2","article-title":". Early metabolic responses in temozolomide treated low-grade glioma patients.","volume":"95","author":"Wyss","year":"2009","journal-title":"J Neurooncol"},{"key":"R23-8-20210204","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1227\/01.NEU.0000171642.49553.B0","article-title":". Positron emission tomography with O-(2-18Ffluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.","volume":"57","author":"Rachinger","year":"2005","journal-title":"Neurosurgery"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-201202000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:03Z","timestamp":1786048083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201202000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318238f51a","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}